A paper published on 1 June 2021 by Torsten Hansen et al titled “First case of postmortem study in a patient vaccinated against SARS-CoV-2” supports what has been predicted by some regarding the mRNA “vaccines”: that the vaccine-induced spike proteins circulate the body (that is, do not remain around the vaccination site).
According to the paper, an 86-year-old male received the first shot of the BNT162b2 mRNA vaccine on 9 January 2021 (day 1). No SARS-CoV-2 symptoms were reported. On day 15, he collapsed during breakfast. On day 18, he was admitted to the hospital for diarrhea and tested negative for SARS-CoV-2 using the PCR test.
On day 25, he tested positive for SARS-CoV-2 using the PCR test. On day 26, he died at 14:30 of “acute renal and respiratory failure”.
Immunogenicity assessment by measuring spike protein (S1) antigen-binding immunoglobulin (Ig) G in the serum samples obtained at day 25 showed antibody response (8.7 U/ml, reference value <0.8–1.2 U/ml; Roche ECLIA™), while (nucleocapsid) NCP-IgG/IgM was not elicited (<0.1 U/ml, reference value >1.0 U/ml; Roche ECLIA™). These results indicate that the patient had already developed relevant immunogenicity through vaccination.
The postmortem study included “molecular mapping of 9 different anatomical parts” using the PCR test (Ct > 45). Although the PCR test at such a high cut-off is questionable, it is at least a crude indicator. The nine anatomical parts tested were: olfactory mucosa, tongue, lungs, trachea, myocardium, kidneys, cerebrum, liver, olfactory bulb. The liver and olfactory bulb tested the negative but the others, including the cerebrum, all tested positive with Ct < 38.
According to the researchers:
Because our patient died approximately 2 days after his first positive SARS-CoV-2 test result, we suppose that the molecular mapping data reflects an early stage of viral infection. An early stage of infection might also explain why different regions such as the olfactory bulb and liver were not (yet) affected by systemic viral spread.
In summary, the results of our autopsy case study in a patient with mRNA vaccine confirm the view that by first dose of vaccination against SARS-CoV-2 immunogenicity can already be induced, while sterile immunity is not adequately developed.
I could be wrong but the paper reads like that the vaccine triggered an immune response (without implying a working immunity) but the spike proteins from the infection and the vaccine had gone through most of the body.
The spike proteins on their own are known to cause damage to lung tissue according to researchers at Salk.
Be sure to subscribe to our mailing list so you get each new Opinyun that comes out!